Daniel Friedman
Managing Director at BroadOak Capital Partners
Washington, District of Columbia
Daniel Friedman, Managing Director at BroadOak Capital Partners is an active investor based in Washington, District of Columbia. This profile covers what Daniel Friedman backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCPEInvestment Bank
- Stages
- Early Stage Venture
- Invests in
- Biotech & PharmaHealthcare & BiotechMedTech & Medical Devices
- Location
- Washington, District of Columbia
- Typical check
- $500K
- Past investments
- 17
Notable investments
LabConnectDiagnostic BioSystemsBiolog, Inc.Pluristyx, Inc.PBS BiotechCodex DNAPrecision Cell SystemsAxol Bioscience Ltd.BioCision
GenomenonHow to reach Daniel Friedman
Angels and operators like Daniel Friedman reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Daniel Friedman
Frequently Asked Questions
What does Daniel Friedman invest in?
Daniel Friedman invests in Biotech & Pharma, Healthcare & Biotech and MedTech & Medical Devices, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Daniel Friedman invest at?
Daniel Friedman typically invests at Early Stage Venture. Lead with traction that fits the stage when you reach out.
What is Daniel Friedman's typical check size?
Daniel Friedman typically writes checks around $500K. Use it as a signal for whether your raise fits their stage.
How do I contact Daniel Friedman?
Unlock Daniel Friedman's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.